What is the potential role of antifibrotic agents for the treatment of liver disease?

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 9, 2008, Pages 496-497

  Schnabl, Bernd ^a   Scholten, David ^a   Brenner, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; ANTIBIOTIC AGENT; ANTIFIBROTIC AGENT; ANTIVIRUS AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTOXIN; FUMAGILLOL CHLOROACETYLCARBAMATE; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; SCLEROPROTEIN; SUNITINIB; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL ACTIVATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; DRUG SAFETY; DRUG TARGETING; FIBROGENESIS; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER REGENERATION; LONG TERM CARE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCAR FORMATION; STELLATE CELL;

ANGIOGENESIS INHIBITORS; FIBRINOLYTIC AGENTS; HUMANS; LIVER CIRRHOSIS;

EID: 51349157015     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1200     Document Type: Article

References (13)

1. Bataller R and Brenner DA (2005) Liver fibrosis. J Clin Invest 2115: 209-218
2. Friedman SL (2008) Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172
3. Bataller R et al. (2003) NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112: 1383-1394
4. Gressner AM and Weiskirchen R (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 10: 76-99
5. Yokohama S et al. (2004) Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. Hepatology 40: 1222-1225
6. Yang L et al. (2005) Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. J Hepatol 43 317-323
7. Seki E et al. (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13: 1324-1332
8. Rutenburg AM et al. (1957) The role of intestinal bacteria in the development of dietary cirrhosis in rats. J Exp Med 106: 1-14
9. Isayama F et al. (2006) LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am J Physiol Gastrointest Liver Physiol 290: G1318-1328
10. Wang YO et al. (2000) Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats. Hepatology 32: 980-989
11. Tugues S et al. (2007) Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. Hepatology 46: 1919-1926
12. Pang R and Poon RT (2006) Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett 242: 151-167
13. Schuppan D and Afdhal NH (2008) Liver cirrhosis. Lancet 371: 838-851